Conference: Rodman and Renshaw Annual Global Investment Conference Date: Tuesday, September 14th 2010 Time: 4:30 - 4:55 PM ET Location: Kennedy Salon (4th FL), New York Palace Hotel New York, New York
Mr. Ren Hu, Vice President of Finance of Weikang, will present the Company's operations, business strategy, financial results, and outlook as well as answer investors' questions during the presentation and at one-on-one meetings.
Investors interested in attending the event should contact their Rodman and Renshaw sales representative. For more information about the conference, please visit http://www.rodmanandrenshaw.com/ .
About Weikang Bio-Technology Group Co., Inc.
Weikang Bio-Technology Group Co., Inc. is principally engaged in developing, manufacturing and distributing Traditional Chinese Medicine (TCM), and health and nutritional supplements in China, in compliance with requisite Chinese licenses and approvals. The Company is also expanding its business scope to develop, manufacture and distribute Chinese herbal extract products and GMP certified western prescription and OTC pharmaceuticals through its acquisition of Tianfang. For more information, please visit http://www.weikangbio.com .
Safe Harbor Statement
This press release contains certain statements that may include
"forward-looking statements." All statements other than statements of
historical fact included herein are "forward-looking statements." These
forward-looking statements are often identified by the use of forward-looking
terminology such as "believes," "expect
|SOURCE Weikang Bio-Technology Group Co., Inc.|
Copyright©2010 PR Newswire.
All rights reserved